VBI Vaccines has Risk Adjusted Performance of 0.01. In connection with Fundamental Indicators, Macroaxis technical analysis interface makes it possible for you to check practical technical drivers of VBI Vaccines as well as the relationship between them. In other words you can use this information to find out if the entity will indeed mirror its model of past prices and volume data or the prices will eventually revert. We found nineteen technical drivers for VBI Vaccines which can be compared to its competition. Please validate VBI VaccinesCoefficient Of Variation, Maximum Drawdown as well as the relationship between Maximum Drawdown and Skewness to decide if VBI Vaccines is priced adequately providing market reflects its prevalent price of 3.03 per share. Given that VBI Vaccines has Jensen Alpha of 0.0, we advise you double-check VBI Vaccines current market performance to make sure the company can sustain itself at some point future time.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of VBI Vaccines volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.
VBI Vaccines Trend Analysis
Use this graph to draw trend lines for VBI Vaccines. You can use it to identify possible trend reversals for VBI Vaccines as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual VBI Vaccines price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
VBI Vaccines Best Fit Change Line
The following chart estimates an ordinary least squares regression model for VBI Vaccines applied against its price change over selected period. The best fit line has a slop of 0.013909 % which means VBI Vaccines will continue generating value for investors. It has 34 observation points and a regression sum of squares at 0.16, which is the sum of squared deviations for the predicted VBI Vaccines price change compared to its average price change.
Current Sentiment - VBIV
VBI Vaccines Investor Sentiment
Most of Macroaxis users are at this time bullish on VBI Vaccines. What is your outlook on investing in VBI Vaccines? Are you bullish or bearish?